Search
Stories, the companies and people Loro tracks, and the primary records behind them — filings, donations, contracts and disclosures.
Story2
OrbiMed-affiliated fund OPI VII reports 12.3% stake in Aspen Neuroscience
A Schedule 13D filed on 6 November 2026 shows OPI VII, a Delaware limited partnership managed by OrbiMed Advisors LLC, holds 3,589,132 shares of Aspen Neuroscience, Inc., equal to approximately 12.3% of the company's outstanding shares.
Two insiders bought $7,210,233 of Electra Therapeutics, Inc. shares between 3 Nov and 5 Nov
Open-market purchases reported on SEC Form 4: Carl L Gordon (Director) $3,605,116; ORBIMED ADVISORS LLC (Director) $3,605,116.
Company or person12
ORBIMED ADVISORS LLC
Company
LIBRA ADVISORS LLC
Company
CITADEL ADVISORS LLC
Company
Commerce Advisors, LLC
Company
PERCEPTIVE ADVISORS LLC
Company
HAMILTON LANE ADVISORS LLC
Company
Encompass Capital Advisors LLC
Company
Forvis Mazars Wealth Advisors, LLC
Company
WASATCH ADVISORS LP
Company
ALPS ADVISORS INC
Company
BAKER BROS. ADVISORS LP
Company
EQ ADVISORS TRUST
Company
Primary record7
Forte Biosciences, Inc. filed SCHEDULE 13G/A
0000947871-26-000799.txt : 20260814 SCHEDULE 13G/A 1 primary_doc.xml X0202 SCHEDULE 13G/A 0000947871-25-000158 0001055951 XXXXXXXX LIVE 2 Common Stock, par value $0.001 per share 06/30/2026 0001419041 Forte Biosciences,
ORBIMED ADVISORS LLC filed SCHEDULE 13G/A
0000947871-26-000805.txt : 20260814 SCHEDULE 13G/A 1 primary_doc.xml X0202 SCHEDULE 13G/A 0001055951 XXXXXXXX LIVE 1 Common Stock, par value $0.0001 per share 06/30/2026 0001422142 Whitehawk Therapeutics, Inc. 00032Q104
ORBIMED ADVISORS LLC filed SCHEDULE 13G
0000947871-26-000803.txt : 20260814 SCHEDULE 13G 1 primary_doc.xml X0202 SCHEDULE 13G 0001055951 XXXXXXXX LIVE Common Stock, par value $0.0001 per share 06/30/2026 0001683553 Spruce Biosciences, Inc. 85209E208 611 Gatewa
ORBIMED ADVISORS LLC filed SCHEDULE 13G/A
0000947871-26-000804.txt : 20260814 SCHEDULE 13G/A 1 primary_doc.xml X0202 SCHEDULE 13G/A 0000947871-25-001019 0001055951 XXXXXXXX LIVE 2 Common Stock, par value $0.001 per share 06/30/2026 0001411685 Vistagen Therapeuti
IMMUNIC, INC. filed SCHEDULE 13G
0000947871-26-000800.txt : 20260814 SCHEDULE 13G 1 primary_doc.xml X0202 SCHEDULE 13G 0001055951 XXXXXXXX LIVE Common Stock, par value $0.0001 per share 06/30/2026 0001280776 Immunic, Inc. 4525EP101 1200 Avenue of the Am
NeuroPace Inc filed SCHEDULE 13G/A
0000947871-26-000802.txt : 20260814 SCHEDULE 13G/A 1 primary_doc.xml X0202 SCHEDULE 13G/A 0000947871-25-000546 0001055951 XXXXXXXX LIVE 8 Common Stock, par value $0.001 per share 06/30/2026 0001528287 NeuroPace, Inc. 641
Lexeo Therapeutics, Inc. filed SCHEDULE 13G
0000947871-26-000801.txt : 20260814 SCHEDULE 13G 1 primary_doc.xml X0202 SCHEDULE 13G 0001055951 XXXXXXXX LIVE Common Stock, par value $0.0001 per share 06/30/2026 0001907108 Lexeo Therapeutics, Inc. 52886X107 345 Park A